$0.55 EPS Expected for First Merchants (FRME), Profile of 5 Analysts Covering Globus Medical (GMED)

June 20, 2017 - By Marie Mckinney

Analysts expect First Merchants Corporation (NASDAQ:FRME) to report $0.55 EPS on July, 25.They anticipate $0.06 EPS change or 12.24% from last quarter’s $0.49 EPS. FRME’s profit would be $21.94 million giving it 18.46 P/E if the $0.55 EPS is correct. After having $0.56 EPS previously, First Merchants Corporation’s analysts see -1.79% EPS growth. The stock decreased 0.34% or $0.14 during the last trading session, reaching $40.62. About shares traded. First Merchants Corporation (NASDAQ:FRME) has risen 59.72% since June 20, 2016 and is uptrending. It has outperformed by 43.02% the S&P500.

Among 11 analysts covering Globus Medical Inc (NYSE:GMED), 5 have Buy rating, 2 Sell and 4 Hold. Therefore 45% are positive. Globus Medical Inc had 22 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Globus Medical Inc (NYSE:GMED) earned “Equalweight” rating by Barclays Capital on Wednesday, July 27. The firm has “Buy” rating given on Friday, May 5 by Canaccord Genuity. The stock of Globus Medical Inc (NYSE:GMED) earned “Market Perform” rating by Leerink Swann on Wednesday, July 27. JMP Securities downgraded the shares of GMED in report on Wednesday, November 9 to “Mkt Perform” rating. The stock of Globus Medical Inc (NYSE:GMED) has “Perform” rating given on Wednesday, November 9 by Oppenheimer. Barclays Capital initiated Globus Medical Inc (NYSE:GMED) on Friday, May 27 with “Equal-Weight” rating. The stock of Globus Medical Inc (NYSE:GMED) has “Overweight” rating given on Monday, September 14 by Morgan Stanley. UBS initiated the shares of GMED in report on Tuesday, September 22 with “Buy” rating. As per Wednesday, July 27, the company rating was downgraded by Wells Fargo. The company was initiated on Monday, September 28 by Morgan Stanley. See Globus Medical Inc (NYSE:GMED) latest ratings:

05/05/2017 Broker: Canaccord Genuity Old Rating: Hold New Rating: Buy Old Target: $30.00 New Target: $37.00 Upgrade
05/05/2017 Broker: Oppenheimer Rating: Hold New Target: $32.00 Maintain
12/04/2017 Broker: Leerink Swann Old Rating: Market Perform New Rating: Outperform New Target: $40.00 Upgrade
23/03/2017 Broker: Oppenheimer Rating: Hold Maintain

Among 4 analysts covering First Merchants (NASDAQ:FRME), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. First Merchants had 8 analyst reports since August 18, 2015 according to SRatingsIntel. The stock of First Merchants Corporation (NASDAQ:FRME) earned “Neutral” rating by SunTrust on Wednesday, December 16. The company was upgraded on Tuesday, August 18 by Zacks. Stephens initiated the stock with “Equal-Weight” rating in Friday, October 2 report. Keefe Bruyette & Woods maintained First Merchants Corporation (NASDAQ:FRME) rating on Thursday, June 1. Keefe Bruyette & Woods has “Buy” rating and $4600 target. The rating was initiated by DA Davidson with “Buy” on Thursday, July 21. The firm has “Overweight” rating by Stephens given on Friday, January 29. The firm has “Buy” rating by DA Davidson given on Wednesday, September 28.

Investors sentiment decreased to 1.36 in 2016 Q4. Its down 0.20, from 1.56 in 2016Q3. It is negative, as 10 investors sold First Merchants Corporation shares while 49 reduced holdings. 25 funds opened positions while 55 raised stakes. 30.52 million shares or 1.12% more from 30.18 million shares in 2016Q3 were reported. 1St Glob Advsrs Inc stated it has 11,345 shares or 0.05% of all its holdings. Paradigm Mgmt Inc reported 48,700 shares stake. First Trust Advsr Lp reported 122,563 shares. 1.69M were reported by Goldman Sachs Gru. Suntrust Banks Inc accumulated 6,509 shares. First Merchants Corporation stated it has 0.16% of its portfolio in First Merchants Corporation (NASDAQ:FRME). Zebra Capital Management Lc holds 0.4% or 35,086 shares in its portfolio. Menta has invested 0.06% in First Merchants Corporation (NASDAQ:FRME). 49,400 are held by Alliancebernstein L P. Connor Clark And Lunn Mngmt Limited has 0.01% invested in First Merchants Corporation (NASDAQ:FRME). Moreover, Swiss Natl Bank has 0% invested in First Merchants Corporation (NASDAQ:FRME). Fifth Third Financial Bank holds 0.01% of its portfolio in First Merchants Corporation (NASDAQ:FRME) for 32,608 shares. Nationwide Fund accumulated 0.02% or 123,948 shares. Credit Suisse Ag holds 0% or 62,942 shares in its portfolio. The Ontario – Canada-based Manufacturers Life Ins The has invested 0.05% in First Merchants Corporation (NASDAQ:FRME).

Since December 30, 2016, it had 12 insider buys, and 4 selling transactions for $893,474 activity. Another trade for 41 shares valued at $1,684 was bought by Lehman Gary. Sherman Patrick A also bought $483 worth of First Merchants Corporation (NASDAQ:FRME) shares. $669,469 worth of First Merchants Corporation (NASDAQ:FRME) was sold by RECHIN MICHAEL C. $225,827 worth of stock was sold by HOY WILLIAM L on Monday, March 13. FLUHLER STEPHAN sold 1,800 shares worth $69,480. WALKER TERRY L also sold $51,654 worth of First Merchants Corporation (NASDAQ:FRME) on Wednesday, June 14.

First Merchants Corporation is a financial holding company. The company has market cap of $1.62 billion. The Firm has a bank charter, First Merchants Bank , which is opened for business in Muncie, Indiana. It has a 19.29 P/E ratio. It operates through community banking business segment.

Globus Medical, Inc. is a medical device company. The company has market cap of $3.22 billion. The Firm is focused on developing products for patients with musculoskeletal disorders. It has a 30.45 P/E ratio. It is focused on products to treat patients with spine disorders.

Investors sentiment increased to 1.15 in 2016 Q4. Its up 0.27, from 0.88 in 2016Q3. It improved, as 35 investors sold Globus Medical Inc shares while 57 reduced holdings. 48 funds opened positions while 58 raised stakes. 64.95 million shares or 1.58% more from 63.94 million shares in 2016Q3 were reported. Moreover, Invesco Ltd has 0% invested in Globus Medical Inc (NYSE:GMED). Royal Bank & Trust Of Canada owns 993,328 shares. Gabelli Funds Ltd Liability Co owns 230,500 shares or 0.03% of their US portfolio. Blackrock Investment Mgmt Limited Liability Corp reported 472,053 shares. Gofen & Glossberg Limited Company Il has invested 0.12% of its portfolio in Globus Medical Inc (NYSE:GMED). Paradigm Asset Management Co Limited holds 0% of its portfolio in Globus Medical Inc (NYSE:GMED) for 9,050 shares. Cornercap Investment Counsel invested in 49,930 shares. First Interstate Commercial Bank holds 0% or 746 shares in its portfolio. Cubist Systematic Strategies Llc invested in 0.02% or 10,697 shares. Johnson Financial Grp owns 895 shares. Finemark Bancorporation And Trust reported 62 shares stake. Baldwin Brothers Ma stated it has 0% in Globus Medical Inc (NYSE:GMED). Liberty Mutual Gp Asset Mngmt accumulated 30,865 shares. Btim Corporation, Massachusetts-based fund reported 522,462 shares. Envestnet Asset stated it has 0% in Globus Medical Inc (NYSE:GMED).

The stock increased 0.85% or $0.28 during the last trading session, reaching $33.23. About shares traded. Globus Medical Inc (NYSE:GMED) has risen 30.88% since June 20, 2016 and is uptrending. It has outperformed by 14.18% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: